Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Look, you guys need to resolve in your mind that this stock won't move until....

Look, you guys need to resolve in your mind that this stock won't move until....

posted on Aug 15, 2008 07:00AM

we receive USPTO resolution. I thought the 10K was what one should expect from a legitmate company, nothing more nothing less. It was by far the best composed financial statement released by PTSC since I've owned it. Now with that said, if you want to actually grade the content that's a different story. As expected we didn't receive any "Surprise" information. There were a few tidbits that offered clarification but any information that one hoped would boost the S/P didn't exist. Even though we all know the potential and the story, there are many who do not. If they only glance at '07/'06 results their assumption would be a strong decrease in revenue and subsequent drop in earnings. What this report does is offer a strong view into the minds of RG and staff. In my mind it brought instant professionalism that the company has been sorely lacking.



The best news from the "K" is that the company did not give up ground. I would say the argument could be made that we are currently in neutral. RG and staff have begun to implement their diversification strategy and obviously appear to be targeting the growing securities industry. We all know that it would probably be years before the revenue generated would be enough to move the stock with a float our size. If you are like me, and I'm sure plenty are, if you are hoping to see your money within the next year the only hope for that is the USPTO and subsequentl licenses that would hopefully follow. All in all I thought it was solid financial reporting and the next step to further validated Patriot as a legimate investment. I look forward to watching Mr. G's plans unfold.

Share
New Message
Please login to post a reply